Literature DB >> 6832367

Red blood cell targeting to collagen-coated surfaces.

G P Samokhin, M D Smirnov, V R Muzykantov, S P Domogatsky, V N Smirnov.   

Abstract

The interaction of human red blood cells carrying antihuman collagen antibody with collagen-coated surfaces was studied. Avidin was used as bifunctional crosslinking agent for the attachment of antibody to the red blood cell surface. Antibody-carrying red blood cells efficiently and specifically bound to collagen-coated surface covering a significant part of the surface. The components of normal blood had an insignificant effect on red blood cell binding. A model of drug targeting to the injured sites(s) of blood vessel wall is proposed.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6832367     DOI： 10.1016/0014-5793(83)80160-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


  13 in total

Review 1.  Drug delivery by red blood cells: vascular carriers designed by mother nature.

Authors:  Vladimir R Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

Review 2.  Erythrocyte-mediated delivery of recombinant enzymes.

Authors:  Vincenzo Leuzzi; Luigia Rossi; Claudia Gabucci; Francesca Nardecchia; Mauro Magnani
Journal:  J Inherit Metab Dis       Date:  2016-03-30       Impact factor: 4.982

3.  Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall.

Authors:  V N Smirnov; S P Domogatsky; V V Dolgov; V B Hvatov; A L Klibanov; V E Koteliansky; V R Muzykantov; V S Repin; G P Samokhin; B V Shekhonin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

Review 4.  Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.

Authors:  Patrick M Glassman; Elizabeth D Hood; Laura T Ferguson; Zongmin Zhao; Don L Siegel; Samir Mitragotri; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2021-09-29       Impact factor: 15.470

Review 5.  Non-affinity factors modulating vascular targeting of nano- and microcarriers.

Authors:  Jacob W Myerson; Aaron C Anselmo; Yaling Liu; Samir Mitragotri; David M Eckmann; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2015-10-24       Impact factor: 15.470

Review 6.  Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier.

Authors:  Carlos H Villa; Daniel C Pan; Sergei Zaitsev; Douglas B Cines; Donald L Siegel; Vladimir R Muzykantov
Journal:  Ther Deliv       Date:  2015-07

Review 7.  Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.

Authors:  Carlos H Villa; Aaron C Anselmo; Samir Mitragotri; Vladimir Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2016-03-03       Impact factor: 15.470

8.  Nanoparticle Attachment to Erythrocyte Via the Glycophorin A Targeted ERY1 Ligand Enhances Binding without Impacting Cellular Function.

Authors:  Kaustuv Sahoo; Rangika S Hikkaduwa Koralege; Nicholas Flynn; Samyukta Koteeswaran; Peter Clark; Steve Hartson; Jing Liu; Joshua D Ramsey; Carey Pope; Ashish Ranjan
Journal:  Pharm Res       Date:  2016-01-26       Impact factor: 4.200

9.  Avidin acylation prevents the complement-dependent lysis of avidin-carrying erythrocytes.

Authors:  V R Muzykantov; M D Smirnov; G P Samokhin
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

Review 10.  Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm.

Authors:  Melissa Howard; Blaine J Zern; Aaron C Anselmo; Vladimir V Shuvaev; Samir Mitragotri; Vladimir Muzykantov
Journal:  ACS Nano       Date:  2014-05-07       Impact factor: 15.881
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.